Search research articles
Contact Us
Filters
Showing results (21-30 of 106) with videos related to
Page
of 11
Sort By:
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Cabergoline for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K D Deane
Postgraduate Medical Journal
|
August 1, 1987
Subacute myelopathy caused by spinal venous infarction
C E Clarke, W J Cumming
Gerontology
|
February 15, 2002
Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve them
P W Overstall, C E Clarke
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Lisuride for levodopa-induced complications in Parkinson's disease
C E Clarke, J M Speller
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Ropinirole for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
July 25, 2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
July 25, 2000
Ropinirole for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, J M Speller
Parkinsonism & Related Disorders
|
October 31, 2012
Retrospective evaluation of the diagnostic accuracy of Parkinsonism in a UK community based movement disorders clinic
B S Simpson, C E Clarke
Page
of 11
Search research articles
Search
Showing results (21-30 of 106) with videos related to
Sort By:
Page
of 11
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Cabergoline for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K D Deane
Postgraduate Medical Journal
|
August 1, 1987
Subacute myelopathy caused by spinal venous infarction
C E Clarke, W J Cumming
Gerontology
|
February 15, 2002
Uncertainties in the pharmacotherapy of Parkinson's disease and how to solve them
P W Overstall, C E Clarke
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Lisuride for levodopa-induced complications in Parkinson's disease
C E Clarke, J M Speller
The Cochrane Database of Systematic Reviews
|
May 2, 2001
Ropinirole for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
July 25, 2000
Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
July 25, 2000
Ropinirole for levodopa-induced complications in Parkinson's disease
C E Clarke, K H Deane
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Lisuride versus bromocriptine for levodopa-induced complications in Parkinson's disease
C E Clarke, J M Speller
Parkinsonism & Related Disorders
|
October 31, 2012
Retrospective evaluation of the diagnostic accuracy of Parkinsonism in a UK community based movement disorders clinic
B S Simpson, C E Clarke
Page
of 11